BioAdaptives, Inc.
BDPT
$0.07
$0.01629.63%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 700.00 | 12.70K | 19.90K | 35.50K | 37.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 700.00 | 12.70K | 19.90K | 35.50K | 37.10K |
| Cost of Revenue | 81.60K | 90.00K | 94.50K | 45.50K | 24.70K |
| Gross Profit | -80.90K | -77.30K | -74.60K | -9.90K | 12.50K |
| SG&A Expenses | 702.40K | 504.80K | 242.80K | 240.10K | 242.80K |
| Depreciation & Amortization | 0.00 | 1.90K | -8.90K | 28.70K | 29.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 784.00K | 596.70K | 328.40K | 314.40K | 297.00K |
| Operating Income | -783.30K | -584.00K | -308.50K | -278.80K | -259.70K |
| Income Before Tax | -789.50K | -899.10K | -795.60K | -771.10K | -732.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.79 | -0.90 | -0.80 | -0.77 | -0.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -789.50K | -899.10K | -795.60K | -771.10K | -732.00K |
| EBIT | -783.30K | -584.00K | -308.50K | -278.80K | -259.70K |
| EBITDA | -782.90K | -582.10K | -299.50K | -232.20K | -212.50K |
| EPS Basic | -0.10 | -0.11 | -0.10 | -0.09 | -0.11 |
| Normalized Basic EPS | -0.06 | -0.07 | -0.06 | -0.04 | -0.05 |
| EPS Diluted | -0.10 | -0.11 | -0.10 | -0.09 | -0.11 |
| Normalized Diluted EPS | -0.06 | -0.07 | -0.06 | -0.04 | -0.05 |
| Average Basic Shares Outstanding | 30.90M | 29.55M | 33.87M | 32.77M | 29.74M |
| Average Diluted Shares Outstanding | 30.90M | 29.55M | 33.87M | 32.77M | 29.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |